Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional studyGlobal health action, 2024-12, Vol.17 (1), p.2325728-2325728 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2325728 ;PMID: 38596846Full text available |
|
2 |
Material Type: Article
|
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2334084-2334084 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2334084 ;PMID: 38563792Full text available |
|
3 |
Material Type: Article
|
Mission 70/26 Project: improving blood pressure control in PortugalBlood pressure, 2024-12, Vol.33 (1), p.2296903 [Peer Reviewed Journal]ISSN: 0803-7051 ;EISSN: 1651-1999 ;DOI: 10.1080/08037051.2023.2296903 ;PMID: 38130081Full text available |
|
4 |
Material Type: Article
|
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccinationHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2321672-2321672 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2321672 ;PMID: 38439670Full text available |
|
5 |
Material Type: Article
|
COVID-19 clinical trial participation and awareness in TexasHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2340692-2340692 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2340692 ;PMID: 38658140Full text available |
|
6 |
Material Type: Article
|
Herpes zoster in older adults: Impact on carbon footprint in the United StatesHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2335722-2335722 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2335722 ;PMID: 38698759Full text available |
|
7 |
Material Type: Article
|
Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patientsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2343544-2343544 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2343544 ;PMID: 38655676Full text available |
|
8 |
Material Type: Article
|
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteersHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2301631-2301631 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2301631 ;PMID: 38189360Full text available |
|
9 |
Material Type: Article
|
Radiographic evaluation of teeth with pulp stones and pulp canal obliteration: characteristics, and associations with dental parametersLibyan journal of medicine, 2024-12, Vol.19 (1), p.2306768-2306768 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2306768 ;PMID: 38258544Full text available |
|
10 |
Material Type: Article
|
Hypophysitis after COVID-19 vaccination in a patient with Rathke's cleft cyst: A case reportHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2297455-2297455 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2297455 ;PMID: 38174857Full text available |
|
11 |
Material Type: Article
|
Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysisHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341454-2341454 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2341454 ;PMID: 38695296Full text available |
|
12 |
Material Type: Article
|
Estimation of cause-specific mortality in Rakai, Uganda, using verbal autopsy 1999-2019Global health action, 2024-12, Vol.17 (1), p.2338635-2338635 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2338635 ;PMID: 38717826Full text available |
|
13 |
Material Type: Article
|
Impact of the COVID-19 pandemic on social media utilization, influences related to parental vaccine decision making, and opinions on trustworthy social media vaccination campaigns: A qualitative analysisHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2311476-2311476 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2311476 ;PMID: 38356267Full text available |
|
14 |
Material Type: Article
|
Prevalence and associated factors for poor mental health among young migrants in Sweden: a cross-sectional studyGlobal health action, 2024-12, Vol.17 (1), p.2294592-2294592 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2023.2294592 ;PMID: 38180014Full text available |
|
15 |
Material Type: Article
|
Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2310916-2310916 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2310916 ;PMID: 38369712Full text available |
|
16 |
Material Type: Article
|
Prevalence of multi-drug resistant bacteria in intensive care units at Tripoli University Hospital, Tripoli, LibyaLibyan journal of medicine, 2024-12, Vol.19 (1), p.2348235-2348235 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2348235 ;PMID: 38718270Full text available |
|
17 |
Material Type: Article
|
Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case reportCancer biology & therapy, 2024-12, Vol.25 (1), p.2338644-2338644 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2024.2338644 ;PMID: 38650446Full text available |
|
18 |
Material Type: Article
|
Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survivalCancer biology & therapy, 2024-12, Vol.25 (1), p.2350249-2350249 [Peer Reviewed Journal]ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2024.2350249 ;PMID: 38722731Full text available |
|
19 |
Material Type: Article
|
Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case reportHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2342133-2342133 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2342133 ;PMID: 38659098Full text available |
|
20 |
Material Type: Article
|
Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemicHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2338953-2338953 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2338953 ;PMID: 38658178Full text available |